What is Kelso Pharma?
Kelso Pharma is focused on introducing innovative, value-added specialty medicines to European healthcare markets. The company's mission is to deliver meaningful benefits to patients and create added value for healthcare stakeholders. By offering cost-effective medicines that improve patient lives, Kelso Pharma aims to enhance the overall healthcare system through ethical practices and a commitment to patient well-being.
How much funding has Kelso Pharma raised?
Kelso Pharma has raised a total of $181M across 1 funding round:
Debt
$181M
Debt (2025): $181M with participation from Apposite Capital
Key Investors in Kelso Pharma
Apposite Capital
Apposite Capital is a private equity firm specializing in the healthcare industry, focusing on lower mid-market investments across Europe. They support healthcare SMEs through management buyouts, growth capital, and strategic guidance to drive substantial growth and positive health impact.
What's next for Kelso Pharma?
The recent major strategic investment positions Kelso Pharma for accelerated growth and market penetration within the European pharmaceutical sector. This substantial backing is expected to fuel the company's expansion efforts, potentially enabling further research and development, broader market access, and the scaling of its specialty medicine portfolio. The enterprise-level funding context suggests a mature stage of development, indicating a strategic focus on solidifying market position and achieving significant commercial milestones.
See full Kelso Pharma company page
